PMID- 17045908 OWN - NLM STAT- MEDLINE DCOM- 20061121 LR - 20221109 IS - 1558-3597 (Electronic) IS - 0735-1097 (Linking) VI - 48 IP - 8 DP - 2006 Oct 17 TI - Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. PG - 1688-97 AB - OBJECTIVES: We aimed to test whether attenuation of early-phase cardiac cell death can prevent diabetic cardiomyopathy. BACKGROUND: Our previous study showed that cardiac apoptosis as a major early cellular response to diabetes is induced by hyperglycemia-derived oxidative stress that activates a mitochondrial cytochrome c-mediated caspase-3 activation pathway. Metallothionein (MT) as a potent antioxidant prevents the development of diabetic cardiomyopathy. METHODS: Diabetes was induced by a single dose of streptozotocin (STZ) (150 mg/kg) in cardiac-specific, metallothionein-overexpressing transgenic (MT-TG) mice and wild-type (WT) controls. On days 7, 14, and 21 after STZ treatment, cardiac apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and caspase-3 activation. Cardiomyopathy was evaluated by cardiac ultrastructure and fibrosis in the diabetic mice 6 months after STZ treatment. RESULTS: A significant reduction in diabetes-induced increases in TUNEL-positive cells, caspase-3 activation, and cytochrome c release from mitochondria was observed in the MT-TG mice as compared to WT mice. Cardiac protein nitration (3-nitrotyrosine [3-NT]) and lipid peroxidation were significantly increased, and there was an increase in mitochondrial oxidized glutathione and a decrease in mitochondrial reduced glutathione in the WT, but not in the MT-TG, diabetic mice. Double staining for cardiomyocytes with alpha sarcomeric actin and caspase-3 or 3-NT confirmed the cardiomyocyte-specific effects. A significant prevention of diabetic cardiomyopathy and enhanced animal survival were observed in the MT-TG diabetic mice as compared to WT diabetic mice. CONCLUSIONS: These results suggest that attenuation of early-phase cardiac cell death by MT results in a significant prevention of the development of diabetic cardiomyopathy. This process is mediated by MT suppression of mitochondrial oxidative stress. FAU - Cai, Lu AU - Cai L AD - Department of Medicine, the University of Louisville, Louisville, Kentucky, USA. L0cai001@louisville.edu FAU - Wang, Yuehui AU - Wang Y FAU - Zhou, Guihua AU - Zhou G FAU - Chen, Teresa AU - Chen T FAU - Song, Ye AU - Song Y FAU - Li, Xiaokun AU - Li X FAU - Kang, Y James AU - Kang YJ LA - eng GR - HL59225/HL/NHLBI NIH HHS/United States GR - HL63760/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20060927 PL - United States TA - J Am Coll Cardiol JT - Journal of the American College of Cardiology JID - 8301365 RN - 0 (Actins) RN - 0 (Antioxidants) RN - 3604-79-3 (3-nitrotyrosine) RN - 42HK56048U (Tyrosine) RN - 9007-43-6 (Cytochromes c) RN - 9038-94-2 (Metallothionein) RN - EC 3.4.22.- (Caspase 3) RN - GAN16C9B8O (Glutathione) RN - ULW86O013H (Glutathione Disulfide) SB - IM MH - Actins/metabolism MH - Animals MH - Antioxidants/*metabolism MH - Apoptosis/drug effects MH - Cardiomyopathies/etiology/*prevention & control MH - Caspase 3/metabolism MH - Cell Death MH - Cytochromes c/metabolism MH - Diabetes Mellitus, Experimental/*complications/metabolism/pathology/physiopathology MH - Enzyme Activation MH - Glutathione/antagonists & inhibitors MH - Glutathione Disulfide/metabolism MH - Lipid Peroxidation MH - Metallothionein/genetics/*metabolism MH - Mice MH - Mice, Transgenic/genetics MH - Mitochondria, Heart/*metabolism MH - Myocardium/metabolism/pathology MH - *Myocytes, Cardiac MH - *Oxidative Stress MH - Sarcomeres/metabolism MH - Survival Analysis MH - Tyrosine/analogs & derivatives/metabolism EDAT- 2006/10/19 09:00 MHDA- 2006/12/09 09:00 CRDT- 2006/10/19 09:00 PHST- 2006/04/07 00:00 [received] PHST- 2006/06/15 00:00 [revised] PHST- 2006/06/19 00:00 [accepted] PHST- 2006/10/19 09:00 [pubmed] PHST- 2006/12/09 09:00 [medline] PHST- 2006/10/19 09:00 [entrez] AID - S0735-1097(06)01909-7 [pii] AID - 10.1016/j.jacc.2006.07.022 [doi] PST - ppublish SO - J Am Coll Cardiol. 2006 Oct 17;48(8):1688-97. doi: 10.1016/j.jacc.2006.07.022. Epub 2006 Sep 27.